Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 275 Lung Neoplasms 106 Adenocarcinoma of Lung 27 Mesothelioma, Malignant 22 Neoplasms 19 Neoplasm Metastasis 18 Breast Neoplasms 13 Brain Neoplasms 13 Mesothelioma 10 Head and Neck Neoplasms 10 Ovarian Neoplasms 8 Colorectal Neoplasms 8 Recurrence 7 Adenocarcinoma, Bronchiolo-Alveolar 7 Small Cell Lung Carcinoma 6 NSCLC 6 Adenocarcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Meningeal Carcinomatosis 5 Carcinoma 5 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Solitary Fibrous Tumor, Pleural 4 Sarcoma 4 Pancreatic Neoplasms 4 Non-small Cell Lung Cancer Metastatic 4 Laryngeal Diseases 4 Carcinoma, Transitional Cell 4 Uterine Neoplasms 3 Uterine Cervical Neoplasms 3

Interventions

Paclitaxel 12 Cisplatin 11 Hyperthermic Intraperitoneal Chemotherapy 10 Cytoreduction Surgical Procedures 9 Oxaliplatin 8 Fluorouracil 7 Mitomycin 6 Carboplatin 5 Leucovorin 4 Bevacizumab 4 catumaxomab 3 Doxorubicin 3 Docetaxel 3 sodium thiosulfate 2 Indocyanine Green 2 Drug Therapy 2 Cetuximab 2 volociximab 1 vandetanib 1 relacorilant 1 pasireotide 1 nilotinib 1 farletuzumab 1 epothilone B 1 enzastaurin 1 birinapant 1 alvimopan 1 Surgical Procedures, Operative 1 Saline Waters 1 Platinum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Peritoneal Neoplasms × Pemetrexed × Clear all

NCT03875144 2026-02-09

MESOTIP

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2 Suspended

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡